<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04804085</url>
  </required_header>
  <id_info>
    <org_study_id>20AN004</org_study_id>
    <nct_id>NCT04804085</nct_id>
  </id_info>
  <brief_title>Anaesthesia for Mechanical Thrombectomy</brief_title>
  <official_title>Conduct of Anaesthesia During Acute Ischaemia Stroke: a Retrospective Case Series of Patients Undergoing Mechanical Thrombectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nottingham University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nottingham University Hospitals NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Title: Conduct of anaesthesia during acute ischaemic stroke: a retrospective case series of&#xD;
      patients undergoing mechanical thrombectomy.&#xD;
&#xD;
      Design: This study will be a retrospective consecutive observational case series&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Aim of this study is to describe the baseline characteristics, procedural and&#xD;
      post-operative clinical characteristics of anaesthetic care delivered to consecutive adult&#xD;
      patients who underwent mechanical thrombectomy as part of their routine clinical care between&#xD;
      01/01/2016 and 01/10/2020 at Nottingham University Hospitals NHS Trust (sample size&#xD;
      approximately 250).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluating the number of patients requiring mechanical thrombectomy</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>This retrospective study will identify the anaesthetic care delivered to a group of patients undergoing mechanical thrombectomy for the management of acute ischaemic stroke. The data collected will be from all patients that received this treatment between 01/01/2016 and 01/10/2020 at Nottingham University Hospitals NHS Trust. This data written up and of interest both to our organisation and to comparable neuroscience centres in the UK and internationally.&#xD;
Outcomes that will be measured in this clinical case study are highlighted below.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Background information: Age (&gt;/= 18 years of age)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background information: Gender (male or female)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>Physiological gender</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background information: The degree of disability/dependence after a stroke will be measured using the presenting modified Rankin Score</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>0 - No symptoms.&#xD;
- No significant disability. Able to carry out all usual activities, despite some symptoms.&#xD;
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.&#xD;
- Moderate disability. Requires some help, but able to walk unassisted.&#xD;
- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.&#xD;
- Severe disability. Requires constant nursing care and attention, bedridden, incontinent.&#xD;
- Dead.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background information: Presenting blood pressure (systolic and diastolic)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background information: Presenting heart rate (beats per minute)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background information: The fitness of the patient will be measured using the American Society of Anaesthetists Classification</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>ASA I A normal healthy patient Healthy ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation ASA VI A declared brain-dead patient whose organs are being removed for donor purposes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background information: Height of the patient (m)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>BMI = Weight / (height x height)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background information: Weight of the patient (kg)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>BMI = Weight / (height x height)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background information: Measuring the distance from referring hospital (miles)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>Hospitals included: Kings Mill Hospital, Royal Derby Hospital, Leicester, Lincoln, Boston, Burton</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The patient's stroke classification will be measured using National Institute for Health Stroke Scale</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mode of anaesthesia</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>Awake / Sedated / Converted on-table to General Anaesthetic / GA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify the anaesthetic agents used</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>Propofol / Alfentanil / Remifentanil / Fentanyl / Midazolam</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of the anaesthetist (registrar / consultant)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra - procedural observations: Measuring time spent with systolic blood pressure (mmHg) &lt;10% of presenting BP (minutes)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra - procedural observations: Quantifying any episodes of hypoxia (SpO2 &lt;94%)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-procedural interventions: Identifying if the patient required vasopressors</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>None / metaraminol / ephedrine / noradrenaline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measuring the response of treatment using the post-procedural Thrombolysis in Cerebral Infarction scale</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>Grade 0: no perfusion Grade 1: penetration with minimal perfusion Grade 2: partial perfusion Grade 2A: only partial filling (less than two-thirds) of the entire vascular territory is visualised Grade 2B: complete filling of all of the expected vascular territory is visualised but the filling is slower than normal Grade 3: complete perfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify the level of care required immediately post procedure (Level 0,1,2,3)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identify the duration of Intensive Care stays (days)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identify the duration of stay in hospital (days)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>Whether in NUH or otherwise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To measure the long term outcome: National Institute for Health Stroke Scale at 24 hours post-procedure</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To measure the long term outcome: Modified Rankin Score at 90 days</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
    <description>0 - No symptoms.&#xD;
- No significant disability. Able to carry out all usual activities, despite some symptoms.&#xD;
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.&#xD;
- Moderate disability. Requires some help, but able to walk unassisted.&#xD;
- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.&#xD;
- Severe disability. Requires constant nursing care and attention, bedridden, incontinent.&#xD;
- Dead.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To measure the long term outcome: Mortality at 90 days (survived / deceased)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To measure the long term outcome: Discharge destination (home / institution)</measure>
    <time_frame>Through study completion, up to 9 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Stroke, Ischemic</condition>
  <condition>Anesthesia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be identified by existing clinical records of mechanical thrombectomy&#xD;
        procedures undertaken at Nottingham University Hospitals and already collated as part of&#xD;
        routine service evaluation and clinical care. Sampling will be consecutive. The sampling&#xD;
        window (01/01/2016-01/10/2020) has been chosen because mechanical thrombectomy is a new&#xD;
        therapy that was not undertaken in current form before 2016.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 years old&#xD;
&#xD;
          -  Undergone mechanical thrombectomy for the management of acute ischaemia stroke between&#xD;
             01/01/2016-01/10/2020 at Nottingham University Hospitals NHS Trust.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No pre-specified exclusion criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Hewson (Consultant Anaesthetist)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nottingham University Hospitals Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Hewson (Consultant Anaesthetist)</last_name>
    <phone>01159249924</phone>
    <phone_ext>61195</phone_ext>
    <email>david.hewson@nuh.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heather Broll (Junior Doctor)</last_name>
    <phone>07717277759</phone>
    <email>heather.broll@nhs.net</email>
  </overall_contact_backup>
  <link>
    <url>https://rcoa.ac.uk/sites/default/files/documents/2020-08/21075%20RCoA%20Audit%20Recipe%20Book_Combined_Final_25.08.2020_0.pdf</url>
    <description>Raising the Standards: RCoA quality improvement compendium, 4th Edition September 2020: 12.7 Endovascular thrombectomy</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2021</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anaesthesia</keyword>
  <keyword>Ischaemic</keyword>
  <keyword>Mechanical</keyword>
  <keyword>Case Series</keyword>
  <keyword>Endovascular</keyword>
  <keyword>Thrombectomy</keyword>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

